Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X P Liu

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Cancer|March 17, 2001
Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcomaS Kawauchi, Y Goto, X P Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)R Malaviya, C L Chen, C Navara, et al.
Pharmaceutical Research|February 9, 1999
Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in miceC L Chen, R Malaviya, C Navara, et al.
European Review for Medical and Pharmacological Sciences|November 5, 2015
Comparison of the after discharges induced by electrical stimulation of the prefrontal cortex in urethane- and ketamine-anesthetized miceX-L Chen, L-Z Kong, X-P Liu, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 15, 2021
[Mid-to-long term clinical outcomes and predictors after anterior cruciate ligament revision]Y F Jiang, J Wang, Y J Wang, et al.
Anti-Cancer Drug Design|April 15, 2000
Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agentsS Ghosh, R K Narla, Y Zheng, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|July 15, 2025
[The clinical research of IFNGR1 proximal promoter polymorphism in susceptibility and prognosis of breast cancer]X P Liu, H Zhou, Y Y Dong, et al.
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica Et Biophysica Sinica|May 30, 2002
Expression, Purification and Functional Identification of Extracellular Part of Discoidin Domain Receptor 2J C Wang, X P Liu, X Y Nie, et al.
Veterinary Research Communications|May 19, 2009
Identification of three immunodominant regions on leukotoxin protein of Fusobacterium necrophorumD B Sun, R Wu, G L Li, et al.
Journal of Medical Engineering & Technology|April 20, 2010
Mineralization and osteoblast response to bioactive glass in vitroZ H Zhou, Q F Yi, H D Nei, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Cancer|March 17, 2001
Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcomaS Kawauchi, Y Goto, X P Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Treatment of allergic asthma by targeting janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3', 5'-dibromo-4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)R Malaviya, C L Chen, C Navara, et al.
Pharmaceutical Research|February 9, 1999
Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in miceC L Chen, R Malaviya, C Navara, et al.
European Review for Medical and Pharmacological Sciences|November 5, 2015
Comparison of the after discharges induced by electrical stimulation of the prefrontal cortex in urethane- and ketamine-anesthetized miceX-L Chen, L-Z Kong, X-P Liu, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 15, 2021
[Mid-to-long term clinical outcomes and predictors after anterior cruciate ligament revision]Y F Jiang, J Wang, Y J Wang, et al.
Anti-Cancer Drug Design|April 15, 2000
Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agentsS Ghosh, R K Narla, Y Zheng, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|July 15, 2025
[The clinical research of IFNGR1 proximal promoter polymorphism in susceptibility and prognosis of breast cancer]X P Liu, H Zhou, Y Y Dong, et al.
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica Et Biophysica Sinica|May 30, 2002
Expression, Purification and Functional Identification of Extracellular Part of Discoidin Domain Receptor 2J C Wang, X P Liu, X Y Nie, et al.
Veterinary Research Communications|May 19, 2009
Identification of three immunodominant regions on leukotoxin protein of Fusobacterium necrophorumD B Sun, R Wu, G L Li, et al.
Journal of Medical Engineering & Technology|April 20, 2010
Mineralization and osteoblast response to bioactive glass in vitroZ H Zhou, Q F Yi, H D Nei, et al.
Pageof 11